Mutations in DEPDC5 cause familial focal epilepsy with variable foci
What this study shows
Exome sequencing and linkage in families with autosomal dominant familial focal epilepsy with variable foci identified loss-of-function mutations in DEPDC5, a GATOR1 subunit, in 5 of 6 additional published large families and in roughly 12% (10/82) of smaller focal-epilepsy families. This is the human genetic anchor for GATOR1's physiological importance: it supports that loss of a GATOR1 subunit produces a human phenotype. Observational genetic association within families, not an interventional study, and the paper carries no mTORC1 readout of its own - the link to the pathway rests on the molecular work (BAR2013, SHE2018), not on this study.
At a glance
| Evidence type | H Human study Marked H because it is direct evidence from a human clinical trial or human cohort; the code names the kind of study, not its quality -- a small, well-run trial is still H. |
| Study type | 3 - Human Observational |
| Model system | Humans; families with focal epilepsy (exome sequencing + linkage; 10/82 families) |
| Journal | Nature Genetics |
| Year | 2013 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1038/ng.2599 · PMID 23542697 |
In the Atlas
Related topics
More studies on this topic
- A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1 (2013)
- Synergistic role of TFEB/TFE3 and mTORC1 in kidney cystogenesis and tumorigenesis (2026)
- SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway (2017)
- Constitutive mTORC1 Activation in Skeletal Muscle Increases Inflammation but is not Sufficient to Impair Glucose Tolerance. (2026)
Was this page useful?
Thank you. Your answer was counted anonymously.